RE:RE:interest in THMr SPCEO said : "So, even light selling can send the stock lower as we are seeing at the moment."
Ok, so "even light buying can send the stock much higher"!!!!!!
I am sick of these light arguments! The company has to adress those "silly arguments that send the stock lower" !
First, they were way ahaid with their salesteam before Trogarzo got approved, in fact they even paid them for doing nothing! The product wasn't approved and they couldn't get to doctors to tell them a whole new product, a life saving product!!, was coming to the market. Not the most smart move from management.....
Further, they did research for how big that market would be, and they came up to between 10000 and 25000 patients..............., but after a year they can't even tell us how many are on our medication!!!!!!
And the progress........., well your last indication of 7 patients........, oh my God!!!! Yes, i think that is it, may God help us!!!
Then, they could give clearly a bomb signal with buying on the open market, investors are looking out for that!
When you expand the salesteam and sales are lacklustre, shouldn't you have to act ????? Costs higher with less income???? Not the best business model!
Deals or intrest from big pharma is 0 !! That is a fact, they have 2 approved products + having a chance with an existing product in the Nash /Nafld market for future income + "katana" ..............., nobody is intrested!!! They are definetely not showing great leadereship, this is the least one can say......!!!
Hoping and praying, why not !!!!